Zimbabwe has declined a major US health deal valued at $367m (£272m) over five years because of the United States' demand for confidential data.
This move was revealed after a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa believed the deal was "skewed".
A government representative later stated that the United States was demanding access to health data for scientific study and profit but refused to guarantee the benefits from future vaccines.
"We are forced to start the difficult and regrettable process of winding down our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the US had donated more than $1.9bn as health assistance to Zimbabwe over the last two decades.
A medical body in Zimbabwe has urged more dialogue to find a agreement acceptable to both sides so the nation's critical HIV programme can proceed.
Wider Implications
Zimbabwe's decision comes after a comparable situation in Kenya, where a high court halted a related health funding agreement after concerns were raised about the security of Kenyans' health data.
Since returning to the presidency last year, US President Donald Trump has drastically cut overseas assistance and shut down the key foreign aid agency.
USAID had managed assistance for the US government, but Trump argued its expenditure was "wasteful" and his administration was pursuing direct bilateral deals to boost transparency and responsibility.
As per reports, 16 nations in Africa have to date agreed to similar agreements, constituting more than $18.3bn in new funding.
Details of the Rejected Deal
The funds for Zimbabwe would have supported "combating HIV/Aids, TB, malaria, maternal and child health, and preparing for epidemics".
"We are confident this collaboration might have yielded immense benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on antiretroviral therapy via US-supported initiatives," Tremont added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"The proposal required Zimbabwe to share its genetic material and health information indefinitely, with no equivalent promise of access to any scientific breakthroughs – like new medicines or tests – that could be developed from that shared data," he stated.
"In essence, our country would supply the raw materials for scientific discovery with no assurance that the end products would be accessible to our people should a future disease outbreak emerge."
National Interest and International Frameworks
He also pointed out that the American exit from the global health body and its pursuit of one-on-one deals were disrupting frameworks previously established through the international health agency.
Mangwana cited its Pathogen Access and Benefit Sharing system created to deal with potential pandemics.
"This mechanism is designed to guarantee that when a nation contributes its information, the benefits – such as medicines and cures – are shared equitably, not commercialised solely by those with the resources to create them."
The government's concerns regarding the US deal "should not be misconstrued as anti-American sentiment," Mangwana stressed.
"We encourage ongoing discussions with our US partners on how future collaboration could be arranged in a manner that respects the sovereignty and dignity of each country."
Health Experts Reaction
A leading public health body expressed it understood the government's concerns, but urged that negotiations should continue considering much of the nation's HIV programmes depended on international support.
"If specific concerns exist, including those relating to information security or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group added.
The situation underscores the ongoing challenges between receiving vital foreign assistance and safeguarding a country's data in an ever more interconnected world.